The "NIH Reform Act" proposes a significant restructuring within the National Institutes of Health by dissolving the existing National Institute of Allergy and Infectious Diseases (NIAID) . This legislation aims to replace NIAID with three distinct and specialized national research institutes. The goal is to create more focused entities for specific areas of health research. The three new institutes established by the bill are the National Institute of Allergic Diseases , the National Institute of Infectious Diseases , and the National Institute of Immunologic Diseases . Each of these institutes will be responsible for conducting and supporting research, training, and health information dissemination within its designated area. This division is intended to streamline and enhance research efforts in these critical fields. A key provision of the bill mandates that the directors for each of these new institutes will be appointed by the President, subject to the advice and consent of the Senate. These appointments will be for fixed terms of five years, with the possibility of one additional reappointment. During the transition period, the Director of the National Institutes of Health will oversee the new institutes until their permanent directors are in place, and all relevant authorities and responsibilities will be systematically transferred.